FDA product code QNV: Adjunctive Hemodynamic Indicator With Decision Point

QNV is the FDA product code for adjunctive hemodynamic indicator with decision point. It is a Class II device, regulated under 21 CFR 870.2220 and reviewed by the Cardiovascular panel. FDA has cleared 2 510(k) submissions under QNV, 1 in the last five years. The average 510(k) review took 110 days (median 110). 1 De Novo request was granted under it.

Definition

An adjunctive hemodynamic indicator with decision point is a device that identifies and monitors hemodynamic condition(s) of interest and provides notifications at a clinically meaningful decision point. This device is intended to be used adjunctively along with other monitoring and patient information.

Classification

FieldValue
Device nameAdjunctive Hemodynamic Indicator With Decision Point
Device classClass II
Regulation21 CFR 870.2220
Review panelCV — Cardiovascular
Medical specialtyCardiovascular
Premarket route510(k)

510(k) clearances per year for QNV

YearClearancesAvg. review days
20211140
2022179

Compare with all 510(k) review times · Search every QNV clearance

Top QNV applicants

ApplicantClearancesLatest
Fifth Eye, Inc.22022-07-14

Most recent QNV clearances

510(k)ApplicantDeviceDecision dateReview days
K221203Fifth Eye, Inc.AHI System2022-07-1479
K212219Fifth Eye, Inc.AHI System2021-12-03140

Recalls for QNV devices

FDA recall records list no recalls for product code QNV.

Frequently asked questions

What is FDA product code QNV?

QNV is the FDA product code for adjunctive hemodynamic indicator with decision point. It is a Class II device, regulated under 21 CFR 870.2220 and reviewed by the Cardiovascular panel.

What device class is QNV?

Class II, regulation 21 CFR 870.2220. Typical premarket route: 510(k).

How long does a 510(k) take for product code QNV?

Across 2 cleared submissions the average was 110 days from receipt to decision (median 110).

Which companies have the most QNV clearances?

Fifth Eye, Inc. (2).

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Cardiovascular product codes · FDA product code lookup · 510(k) database search · 510(k) review times